Huachuan Zhang
Haikou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Periostin Acts as a Bridge between Gestational Diabetes Mellitus (GDM) and Chronic Inflammation to Modulate Insulin Resistance by Modulating PPARα/NF-κB/TNF-α Signaling Pathway.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: September 27, 2022
Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.
Journal: Endokrynologia Polska
Published: March 15, 2022
An Investigation on the Risk Factors of Thyroid Diseases in Community Population in Hainan.
Journal: International journal of endocrinology
Published: December 14, 2021
Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.
Journal: Frontiers in endocrinology
Published: September 16, 2021
The Impact of Different Insulin-Related Measures on the Risk of Prediabetes Among the Chinese Han Population.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: April 29, 2021
Low prevalence of vitamin D deficiency in adult residents in Hainan, the tropical island province of China.
Journal: Annals of palliative medicine
Published: March 26, 2021
Type 2 diabetes is more predictable in women than men by multiple anthropometric and biochemical measures.
Journal: Scientific reports
Published: September 22, 2020
The correlation between proinsulin, true insulin, proinsulin: True insulin ratio, 25(OH) D3, waist circumference and risk of prediabetes in Hainan Han adults.
Journal: PloS one
Published: September 29, 2019
Gender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitus.
Journal: Journal of diabetes and its complications
Published: November 16, 2015
A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus.
Journal: Experimental and therapeutic medicine
Published: October 19, 2015
Last Updated: 09/26/2026